235 related articles for article (PubMed ID: 18385769)
1. Gene-modified bone marrow cell therapy for prostate cancer.
Wang H; Thompson TC
Gene Ther; 2008 May; 15(10):787-96. PubMed ID: 18385769
[TBL] [Abstract][Full Text] [Related]
2. IL-12 gene-modified bone marrow cell therapy suppresses the development of experimental metastatic prostate cancer.
Wang H; Yang G; Timme TL; Fujita T; Naruishi K; Frolov A; Brenner MK; Kadmon D; Thompson TC
Cancer Gene Ther; 2007 Oct; 14(10):819-27. PubMed ID: 17627292
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis and treatment of prostate cancer bone metastases: targeting the lethal phenotype.
Loberg RD; Logothetis CJ; Keller ET; Pienta KJ
J Clin Oncol; 2005 Nov; 23(32):8232-41. PubMed ID: 16278478
[TBL] [Abstract][Full Text] [Related]
4. Targeting cancer by transcriptional control in cancer gene therapy and viral oncolysis.
Dorer DE; Nettelbeck DM
Adv Drug Deliv Rev; 2009 Jul; 61(7-8):554-71. PubMed ID: 19394376
[TBL] [Abstract][Full Text] [Related]
5. Targeting of therapeutic agents to bone to treat metastatic cancer.
Bagi CM
Adv Drug Deliv Rev; 2005 May; 57(7):995-1010. PubMed ID: 15876400
[TBL] [Abstract][Full Text] [Related]
6. Transcriptionally regulated, prostate-targeted gene therapy for prostate cancer.
Lu Y
Adv Drug Deliv Rev; 2009 Jul; 61(7-8):572-88. PubMed ID: 19393705
[TBL] [Abstract][Full Text] [Related]
7. Integrating the biological characteristics of oncolytic viruses and immune cells can optimize therapeutic benefits of cell-based delivery.
Thorne SH; Contag CH
Gene Ther; 2008 May; 15(10):753-8. PubMed ID: 18356814
[TBL] [Abstract][Full Text] [Related]
8. In situ gene therapy for prostate cancer.
Thompson TC
Oncol Res; 1999; 11(1):1-8. PubMed ID: 10451026
[TBL] [Abstract][Full Text] [Related]
9. Bone metastases in prostate cancer: a targeted approach.
Storey JA; Torti FM
Curr Opin Oncol; 2007 May; 19(3):254-8. PubMed ID: 17414645
[TBL] [Abstract][Full Text] [Related]
10. [Gene therapy].
Gotoh A; Shirakawa T; Wada Y; Hinata N; Terao S; Hara I; Arakawa S; Kamidono S; Okada H; Takenaka A; Fujisawa M
Hinyokika Kiyo; 2005 Feb; 51(2):75-9. PubMed ID: 15773357
[TBL] [Abstract][Full Text] [Related]
11. FOCUS on FOCIS: combined chemo-immunotherapy for the treatment of hormone-refractory metastatic prostate cancer.
Rozková D; Tiserová H; Fucíková J; Last'ovicka J; Podrazil M; Ulcová H; Budínský V; Prausová J; Linke Z; Minárik I; Sedivá A; Spísek R; Bartůnková J
Clin Immunol; 2009 Apr; 131(1):1-10. PubMed ID: 19201656
[TBL] [Abstract][Full Text] [Related]
12. Biological principles and clinical development of prostate cancer gene therapy.
Sanda MG
Semin Urol Oncol; 1997 Feb; 15(1):43-55. PubMed ID: 9050139
[TBL] [Abstract][Full Text] [Related]
13. Gene therapy for prostate cancer.
Gdor Y; Timme TL; Miles BJ; Kadmon D; Thompson TC
Expert Rev Anticancer Ther; 2002 Jun; 2(3):309-21. PubMed ID: 12113054
[TBL] [Abstract][Full Text] [Related]
14. Cell carriers to deliver oncolytic viruses to sites of myeloma tumor growth.
Munguia A; Ota T; Miest T; Russell SJ
Gene Ther; 2008 May; 15(10):797-806. PubMed ID: 18356812
[TBL] [Abstract][Full Text] [Related]
15. A paradigm for the treatment of prostate cancer bone metastases based on an understanding of tumor cell-microenvironment interactions.
Loberg RD; Gayed BA; Olson KB; Pienta KJ
J Cell Biochem; 2005 Oct; 96(3):439-46. PubMed ID: 15988761
[TBL] [Abstract][Full Text] [Related]
16. Gene therapy: principles and potential.
Taneja SS; Pang S; Cohan P; Belldegrun A
Cancer Surv; 1995; 23():247-66. PubMed ID: 7542564
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer gene therapy: outcome of basic research and clinical trials.
Nasu Y; Djavan B; Marberger M; Kumon H
Tech Urol; 1999 Dec; 5(4):185-90. PubMed ID: 10591255
[TBL] [Abstract][Full Text] [Related]
18. Prostate cancer gene therapy and the role of radiation.
Kaminski JM; Nguyen K; Buyyounouski M; Pollack A
Cancer Treat Rev; 2002 Feb; 28(1):49-64. PubMed ID: 12027414
[TBL] [Abstract][Full Text] [Related]
19. Targeting therapeutic gene expression to human prostate cancers.
Maitland NJ
Curr Opin Mol Ther; 2000 Aug; 2(4):389-99. PubMed ID: 11249769
[TBL] [Abstract][Full Text] [Related]
20. Understanding the biology of bone metastases: key to the effective treatment of prostate cancer.
Logothetis CJ; Navone NM; Lin SH
Clin Cancer Res; 2008 Mar; 14(6):1599-602. PubMed ID: 18347159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
